Hologic Announces Financial Results for Second Quarter of Fiscal 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Hologic Announces Financial Results for Second Quarter of Fiscal 2018

Hologic (HOLX) PT Lowered to $40 at RBC Capital

May 3, 2018 8:47 AM EDT

RBC Capital lowered its price target on Hologic (NASDAQ: HOLX) to $40.00 (from $44.00) while maintaining a Sector Perform rating.

... More

Hologic (HOLX) PT Lowered to $40.50 at Evercore ISI

May 3, 2018 7:37 AM EDT

Evercore ISI lowered its price target on Hologic (NASDAQ: HOLX) to $40.50 (from $42.50) while maintaining a Outperform rating.

... More

Hologic (HOLX) PT Lowered to $43 at Needham & Company; 'Ugly Write-Down for Aesthetics Business'

May 3, 2018 6:43 AM EDT

Needham & Company lowered its price target on Hologic (NASDAQ: HOLX) to $43.00 (from $50.00) while maintaining a Buy rating.

Analyst Mike Matson commented, " HOLX's F2Q18 revenue beat and EPS met consensus. But management lowered its FY18 revenue guidance due to Cynosure and... More

Hologic (HOLX) Reports In-Line Q2 EPS; Lowers Rev Guidance, Maintains EPS

May 2, 2018 4:05 PM EDT

Hologic (NASDAQ: HOLX) reported Q2 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue for the quarter came in at $789.3 million versus the consensus estimate of $781.84 million.

GUIDANCE:

Hologic sees FY2018 revenue of $3.18-3.21 million, versus the consensus of $3.25... More